Talaris Therapeutics Inc

NASDAQ:TALS   3:59:52 PM EDT
13.86
+0.59 (+4.45%)
Other Pre-Announcement

Talaris Therapeutics Announces Q2 Loss Per Share Of $0.41

Published: 08/12/2021 11:46 GMT
Talaris Therapeutics Inc (TALS) - Talaris Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update.
Q2 Loss per Share $0.41.
Q2 Earnings per Share Estimate $-0.26 -- Refinitiv Ibes Data (analyst estimates).
Finished Q2 of 2021 With $266.2 Million in Cash, Cash Equivalents and Marketable Securities.
Current Cash and Cash Equivalents Are Expected to Fund Pipeline Development and Operations Into 2025.